Form 4 for NAUT Nautilus Biotechnology, Inc.
Accepted 2022-05-10 00:00:00 ET · period of report 2022-05-09 · accession 0001808805-22-000054 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-10 | 2022-05-09 | NAUT | Patel Sujal M | CEO, Pres, Sec, Dir, 10% | P - Purchase | $3.96 | +50.0K | 9.96M | +0.5% | +$198.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-09 | P | A | 50,000 | $3.96 | 9,964,488 | D | — | — | (F1) Represents the weighted average share price of an aggregate total of 50,000 shares purchased in the price range of $3.8299 to $4.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |